Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dexmedetomidine vs. Remifentanil for Patient and Surgeon Satisfaction in Cataract Surgery Under Controlled Sedation

NCT03401606 is registered in ClinicalTrials.gov with Fundación Universitaria de Ciencias de la Salud as lead sponsor.

NCT NCT03401606
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03401606 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dexmedetomidine vs. Remifentanil for Patient and Surgeon Satisfaction in Cataract Surgery Under Controlled Sedation
Lead sponsor
Fundación Universitaria de Ciencias de la Salud
Phase
Phase 4
Overall status
Terminated
Start date
November 1, 2014
Completion date
January 30, 2016
Enrollment
98 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

failed conscious sedation during procedure